Tregs CD25 CXCL9 in Vitiligo

Clinical trial NCT05569096 · UNKNOWN

Trial details

NCT number: NCT05569096
Sponsor: Assiut University
Status: UNKNOWN
Study type: OBSERVATIONAL

Vitiligo CD25 Deficiency Chemokine (C-X-C Motif)Tregs

Start date: 2024-01-01
Primary completion: 2025-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.